Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$2.91 - $3.83 $509,250 - $670,250
-175,000 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$3.47 - $4.75 $6.24 Million - $8.54 Million
-1,797,000 Reduced 91.13%
175,000 $646,000
Q4 2020

Feb 10, 2021

BUY
$3.2 - $4.98 $390,400 - $607,560
122,000 Added 6.59%
1,972,000 $8.41 Million
Q3 2020

Nov 12, 2020

BUY
$3.69 - $7.09 $1.2 Million - $2.3 Million
325,000 Added 21.31%
1,850,000 $7.22 Million
Q2 2020

Aug 11, 2020

SELL
$3.58 - $7.44 $89,500 - $186,000
-25,000 Reduced 1.61%
1,525,000 $11.3 Million
Q1 2020

May 14, 2020

BUY
$3.49 - $9.2 $1.75 Million - $4.6 Million
500,000 Added 47.62%
1,550,000 $6.96 Million
Q4 2019

Feb 11, 2020

BUY
$6.27 - $11.41 $2.35 Million - $4.28 Million
375,000 Added 55.56%
1,050,000 $8.57 Million
Q3 2019

Nov 05, 2019

BUY
$4.75 - $8.38 $3.21 Million - $5.66 Million
675,000 New
675,000 $4.73 Million
Q1 2019

May 13, 2019

SELL
$6.1 - $10.3 $1.83 Million - $3.09 Million
-300,000 Closed
0 $0
Q4 2018

Feb 11, 2019

SELL
$5.84 - $11.92 $3.27 Million - $6.68 Million
-560,000 Reduced 65.12%
300,000 $1.86 Million
Q3 2018

Nov 13, 2018

BUY
$12.43 - $29.76 $2.92 Million - $6.99 Million
235,000 Added 37.6%
860,000 $10.7 Million
Q2 2018

Aug 14, 2018

BUY
$18.75 - $28.46 $10.2 Million - $15.4 Million
542,685 Added 659.28%
625,000 $17.5 Million
Q1 2018

May 08, 2018

BUY
$15.91 - $20.82 $1.31 Million - $1.71 Million
82,315 New
82,315 $1.65 Million

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $40M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Tamarack Advisers, LP Portfolio

Follow Tamarack Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tamarack Advisers, LP with notifications on news.